148 related articles for article (PubMed ID: 32807356)
1. Amide-sialoside protein conjugates as neomucin bioshields prevent influenza virus infection.
Zhong M; Yu Y; Song JQ; Jia TW; Liu AY; Zhao TF; He HJ; Yang MB; Zhang WX; Yang Y
Carbohydr Res; 2020 Sep; 495():108088. PubMed ID: 32807356
[TBL] [Abstract][Full Text] [Related]
2. Preparation of eicosavalent triazolylsialoside-conjugated human serum albumin as a dual hemagglutinin/neuraminidase inhibitor and virion adsorbent for the prevention of influenza infection.
Li Y; Liu HY; Yang MJ; Liu D; Song JQ; Lao Z; Chen Y; Yang Y
Carbohydr Res; 2023 Oct; 532():108918. PubMed ID: 37586142
[TBL] [Abstract][Full Text] [Related]
3. Multivalent S-sialoside protein conjugates block influenza hemagglutinin and neuraminidase.
Yang Y; Liu HP; Yu Q; Yang MB; Wang DM; Jia TW; He HJ; He Y; Xiao HX; Iyer SS; Fan ZC; Meng X; Yu P
Carbohydr Res; 2016 Nov; 435():68-75. PubMed ID: 27710815
[TBL] [Abstract][Full Text] [Related]
4. Guanidinothiosialoside-Human Serum Albumin Conjugate Mimics mucin Barrier to Restrict Influenza Infection.
Yu Y; Zhou JP; Jin YH; Wang X; Shi XX; Yu P; Zhong M; Yang Y
Int J Biol Macromol; 2020 Nov; 162():84-91. PubMed ID: 32522538
[TBL] [Abstract][Full Text] [Related]
5. Synthetic pentatrideca-valent triazolylsialoside inhibits influenza virus hemagglutinin/neuraminidase and aggregates virion particles.
Lao Z; Li Y; Mi X; Tang Q; Li J; Chen Y; Yang Y
Eur J Med Chem; 2023 Nov; 259():115578. PubMed ID: 37467617
[TBL] [Abstract][Full Text] [Related]
6. Multivalent oleanolic acid human serum albumin conjugate as nonglycosylated neomucin for influenza virus capture and entry inhibition.
Yang Y; He HJ; Chang H; Yu Y; Yang MB; He Y; Fan ZC; Iyer SS; Yu P
Eur J Med Chem; 2018 Jan; 143():1723-1731. PubMed ID: 29146135
[TBL] [Abstract][Full Text] [Related]
7. Oseltamivir modified bovine serum albumin inhibits neuraminidase activity and accumulates virion particles to disturb influenza virus replication.
Qin HJ; Li S; Zhu YB; Bao YB; Tang Q; Liu WB; Zhong M; Zhao Y; Yang Y
Carbohydr Res; 2022 Oct; 520():108631. PubMed ID: 35839640
[TBL] [Abstract][Full Text] [Related]
8. Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
McKimm-Breschkin JL; Barrett S; McKenzie-Kludas C; McAuley J; Streltsov VA; Withers SG
Antiviral Res; 2019 Sep; 169():104542. PubMed ID: 31233807
[TBL] [Abstract][Full Text] [Related]
9. Thiosialoside-decorated polymers use a two-step mechanism to inhibit both early and late stages of influenza virus infection.
Yu Y; Qin HJ; Shi XX; Song JQ; Zhou JP; Yu P; Fan ZC; Zhong M; Yang Y
Eur J Med Chem; 2020 Aug; 199():112357. PubMed ID: 32428793
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase inhibitors as antiviral agents.
Alymova IV; Taylor G; Portner A
Curr Drug Targets Infect Disord; 2005 Dec; 5(4):401-9. PubMed ID: 16535861
[TBL] [Abstract][Full Text] [Related]
11. Assembly of Poly(ethylene glycol)ylated Oleanolic Acid on a Linear Polymer as a Pseudomucin for Influenza Virus Inhibition and Adsorption.
Zhou J; Rong XL; Cao X; Tang Q; Liu D; Jin YH; Shi XX; Zhong M; Zhao Y; Yang Y
Biomacromolecules; 2022 Aug; 23(8):3213-3221. PubMed ID: 35797332
[TBL] [Abstract][Full Text] [Related]
12. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.
Greengard O; Poltoratskaia N; Leikina E; Zimmerberg J; Moscona A
J Virol; 2000 Dec; 74(23):11108-14. PubMed ID: 11070006
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors targeting the influenza virus hemagglutinin.
Li F; Ma C; Wang J
Curr Med Chem; 2015; 22(11):1361-82. PubMed ID: 25723505
[TBL] [Abstract][Full Text] [Related]
14. The medicinal potential of influenza virus surface proteins: hemagglutinin and neuraminidase.
Xie Y; Gong J; Li M; Fang H; Xu W
Curr Med Chem; 2011; 18(7):1050-66. PubMed ID: 21254972
[TBL] [Abstract][Full Text] [Related]
15. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
Huang L; Zhou JF; Wei H; Shu YL
Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Inhibition of Influenza A Virus Adhesion by Di- and Trivalent Hemagglutinin Inhibitors.
Lu W; Du W; Somovilla VJ; Yu G; Haksar D; de Vries E; Boons GJ; de Vries RP; de Haan CAM; Pieters RJ
J Med Chem; 2019 Jul; 62(13):6398-6404. PubMed ID: 31251606
[TBL] [Abstract][Full Text] [Related]
17. Anti-influenza drugs and neuraminidase inhibitors.
Roberts NA
Prog Drug Res; 2001; Spec No():35-77. PubMed ID: 11548210
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture.
Baigent SJ; McCauley JW
Virus Res; 2001 Nov; 79(1-2):177-85. PubMed ID: 11551658
[TBL] [Abstract][Full Text] [Related]
19. Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.
Mishin VP; Novikov D; Hayden FG; Gubareva LV
J Virol; 2005 Oct; 79(19):12416-24. PubMed ID: 16160169
[TBL] [Abstract][Full Text] [Related]
20. Strategies of development of antiviral agents directed against influenza virus replication.
Hsieh HP; Hsu JT
Curr Pharm Des; 2007; 13(34):3531-42. PubMed ID: 18220789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
